Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Individualized postoperative analgesia after thyroid or parathyroid surgery
ChiCTR2300075950Phase 4Not yet recruiting
- Sponsor
- Qilu Hospital of Shandong University Dezhou Hospital
- Start
- Sep 2023
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of sufentanil and ondansetron in postoperative pain (2 arms), sponsored by Qilu Hospital of Shandong University Dezhou Hospital. Primary endpoint: Numeric Pain Rating Scale. Planned start Sep 2023; status: not yet recruiting.
02
Drugs
sufentanilondansetron
03
Conditions
postoperative pain
Beyond the preview
Go deeper on ChiCTR2300075950.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2300075950.